Factors determining the persistence or recurrence of well-differentiated thyroid cancer treated by thyroidectomy and/or radioiodine in the Boston, Massachusetts area: A retrospective chart review
Open Access
- 1 January 2011
- journal article
- Published by Springer Nature in Thyroid Research
- Vol. 4 (1) , 9
Abstract
To assess predictors of well-differentiated thyroid cancer (WDTC) persistence/recurrence. This was a retrospective chart review of thyroid carcinoma patients seen 1979-2007 in a Boston, Massachusetts-area multispecialty group. Of 1,025 patients, 431 met eligibility criteria. Cox proportional hazards models were used to assess predictors (gender, age, ethnicity, tumor size, surgical histology) of WDTC persistence/recurrence (elevated thyroglobulin levels with negative thyroglobulin-antibodies; or positive imaging). Local extension of disease and lymph node involvement could not be assessed. Mean age at initial surgery (n = 431, 74% women, 79% Caucasian) was 45.8 ± 13.5(SD) years. Mean tumor (papillary, 91%; follicular, 5%; Hurthle cell, 2%; ≥1 type, 2%) size was 2.5 ± 1.6(SD) cm. Most tumors were unifocal (57%) and ≥1 cm (89%). Over 2,600 person-years of follow-up, persistence/recurrence occurred in 52 patients (12%) 4.3 years (median; range 0.2-23.2 years) after surgery. Gender, ethnicity, tumor size, multifocality, and histology were not predictive of persistence/recurrence, while older age was predictive in some models. In WDTC patients treated by total and near total thyroidectomy and radioiodine and analyzed without consideration of local, locoregional, and distant extent of disease, neither size of tumor nor male gender contribute to disease persistence/recurrence. Age at diagnosis seems to have some positive prognostic value even if only patients older than 21 years at diagnosis are considered. Due to the rare occurrence of follicular (also oxyphilic) histotype, this conclusion refers mainly to patients with papillary thyroid cancer.Keywords
This publication has 15 references indexed in Scilit:
- Thyroid Cancer Recurrence in Patients Clinically Free of Disease with Undetectable or Very Low Serum Thyroglobulin ValuesThe Journal of Clinical Endocrinology & Metabolism, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Recurrence After Treatment of Micropapillary Thyroid CancerThyroid®, 2009
- Survival impact of treatment options for papillary microcarcinoma of the thyroidThe Laryngoscope, 2009
- Prognostic Factors Affecting Neck Lymph Node Recurrence and Distant Metastasis in Papillary Microcarcinoma of the Thyroid: Results of a Study in 445 PatientsThyroid®, 2009
- Influence of age and primary tumor size on the risk for residual/recurrent well‐differentiated thyroid carcinomaHead & Neck, 2009
- Serum thyroglobulin determination in thyroid cancer patientsBest Practice & Research Clinical Endocrinology & Metabolism, 2008
- Management of Low-Risk Differentiated Thyroid CancerEndocrine Practice, 2007
- Presidential address: Beyond risk groups—A new look at differentiated thyroid cancerSurgery, 1998
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994